Literature DB >> 1444452

Ethanol and oleate inhibition of alpha-ketoisovalerate and 3-hydroxyisobutyrate metabolism by isolated hepatocytes.

H Hu1, J A Jaskiewicz, R A Harris.   

Abstract

Ethanol inhibited glucose synthesis from alpha-ketoisovalerate by isolated rat hepatocytes without significant inhibition of flux through the branched-chain alpha-ketoacid dehydrogenase complex. Accumulation of 3-hydroxyisobutyrate, an intermediate in the catabolism of alpha-ketoisovalerate, was increased by ethanol, indicating inhibition of flux at the level of 3-hydroxyisobutyrate dehydrogenase. 3-Hydroxybutyrate caused the same effects as ethanol, suggesting inhibition was a consequence of an increase in the mitochondrial NADH/NAD+ ratio. Flux through the 3-hydroxyisobutyrate dehydrogenase was more sensitive to regulation by the mitochondrial NADH/NAD+ ratio than flux through the branched-chain alpha-ketoacid dehydrogenase. Oleate also inhibited glucose synthesis from alpha-ketoisovalerate, but marked inhibition of flux through the branched-chain alpha-ketoacid dehydrogenase complex was caused by this substrate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444452     DOI: 10.1016/0003-9861(92)90243-p

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

Review 1.  Branched-chain amino acids in metabolic signalling and insulin resistance.

Authors:  Christopher J Lynch; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

2.  Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.

Authors:  Nishanth E Sunny; Srilaxmi Kalavalapalli; Fernando Bril; Timothy J Garrett; Manisha Nautiyal; Justin T Mathew; Caroline M Williams; Kenneth Cusi
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-09       Impact factor: 4.310

Review 3.  Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.

Authors:  Sean H Adams
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

4.  Liver proteome analysis in a rodent model of alcoholic steatosis.

Authors:  Billy W Newton; William K Russell; David H Russell; Shashi K Ramaiah; Arul Jayaraman
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

5.  3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism.

Authors:  Mona S Nilsen; Regine Å Jersin; Arve Ulvik; André Madsen; Adrian McCann; Per-Arne Svensson; Maria K Svensson; Bjørn G Nedrebø; Oddrun A Gudbrandsen; Grethe S Tell; C R Kahn; Per M Ueland; Gunnar Mellgren; Simon N Dankel
Journal:  Diabetes       Date:  2020-06-25       Impact factor: 9.461

Review 6.  The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism.

Authors:  Mee-Sup Yoon
Journal:  Nutrients       Date:  2016-07-01       Impact factor: 5.717

7.  Exploring Valine Metabolism in Astrocytic and Liver Cells: Lesson from Clinical Observation in TBI Patients for Nutritional Intervention.

Authors:  Sarah Sonnay; Nicolas Christinat; Jonathan Thevenet; Andreas Wiederkehr; Anirikh Chakrabarti; Mojgan Masoodi
Journal:  Biomedicines       Date:  2020-11-10

Review 8.  Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction.

Authors:  Federico Ferro; Renza Spelat; Camilla Valente; Paolo Contessotto
Journal:  Biomolecules       Date:  2022-07-11

9.  Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice.

Authors:  Béatrice S-Y Choi; Noëmie Daniel; Vanessa P Houde; Adia Ouellette; Bruno Marcotte; Thibault V Varin; Cécile Vors; Perrine Feutry; Olga Ilkayeva; Marcus Ståhlman; Philippe St-Pierre; Fredrik Bäckhed; Angelo Tremblay; Phillip J White; André Marette
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.